seventeenth meeting parties decided dec xvii acknowledging parties operating paragraph article montreal protocol phased chlorofluorocarbons specific conditions apply essential use exemption consumption chlorofluorocarbons manufacture metered dose inhalers specified meeting parties concerned parties operating paragraph article protocol consume chlorofluorocarbons manufacture metered dose inhalers may find difficult phase substances without incurring economic losses countries calling upon parent pharmaceutical companies accelerate transfer non chlorofluorocarbon technologies joint venture partners developing countries noting need work undertaken assemble document new non ozone depleting substances methods technology metered dose inhalers would allow elimination uses chlorofluorocarbons noting concern serious risk that parties operating paragraph article consumption levels chlorofluorocarbons metered dose inhaler uses may exceed allowable amounts aware critical need parties operating paragraph article consumption metered dose inhalers protecting human health recognizing also difficulties may faced parties operating paragraph article obtaining sufficient supply annex a group chlorofluorocarbons controlled substances period consider eighteenth meeting parties possible decision would address difficulties parties operating paragraph article may face relation metered dose inhalers request executive committee multilateral fund examine situations consider options might assist potential situation non compliance request executive committee consider appropriate regional workshops create awareness educate stakeholders including doctors patients alternative metered dose inhalers elimination chlorofluorocarbons metered dose inhaler uses technical assistance article parties phase use request open ended working group twenty sixth meeting consider issue